CVM Improves Its Cumulative Adverse Drug Experience Summaries Website

摘要

There is a new look to the "Cumulative Adverse Drug Experience Summaries" on the Center for Veterinary Medicine's (CVM) website. The revised format should improve readers' interpretation of adverse drug experiences associated with specific animal drugs. New animal drugs are evaluated for safety and effectiveness before they are approved by the Food and Drug Administration (FDA). However, testing is done in a limited number of animals and in controlled settings. Less common adverse drug events that could arise during real-world usage might not be detected during pre-approval testing. CVM scientists use reports of adverse drug experiences (ADE) to monitor a new animal drug after it is approved. The ADE reports are assembled into an ADE database. The ADE database helps CVM scientists decide whether there should be changes to product labeling or other regulatory action.